Prescription patterns of antidepressants: Findings from a US claims database

Current Medical Research and Opinion

Volumn 26, Issue 6, 2010, Pages 1343-1353

  Milea, Dominique ^a,b   Verpillat, Patrice ^a   Guelfucci, Florent ^c   Toumi, Mondher ^a   Lamure, Michel ^a  

^a Lundbeck   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Altipharm   (France)

Author keywords

Antidepressant; Anxiety; Comorbidities; Database; Depression; Diagnosis of interest; Prescription

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG LABELING; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHARMACEUTICAL CARE; PRESCRIPTION; PSYCHOTHERAPY; SCHIZOPHRENIA; TREATMENT DURATION; UNITED STATES;

ADULT; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DEPRESSION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; YOUNG ADULT;

EID: 77952469875     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003772096     Document Type: Article

References (14)

1. Beck CA, Patten SB, Williams JV, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 2005;40:799-807
2. Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008;77:83-92
3. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007; 16:560-570
4. Brugha TS, Bebbington PE, Singleton N, et al. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004;185:378-384
5. Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 2003;326:1008
6. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002;287:203-209 (Pubitemid 34251945)
7. Isacsson G, Boethius G, Henriksson S, et al. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22
8. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs. Pediatrics 1996;98:143-145
9. Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician 2003;68:498-504
10. Gichangi A, Andersen M, Kragstrup J, et al. Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice. Pharmacoepidemiol Drug Saf 2006;15:167-177
11. Sheehan DV, Keene MS, Eaddy M, et al. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepres-sant agents in patients with depression and/or anxiety disorders. CNS Drugs 2008;22:963-973
12. Gardarsdottir H, Heerdink ER, van Dijk L, et al. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007;98:109-115
13. Henriksson S, Boethius G, Hakansson J, et al. Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995. Acta Psychiatr Scand 2003;108:427-431
14. Trifiro G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007;16:552-559